Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 71INDUSTRY 13NIH 7NETWORK 5OTHER_GOV 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Plasma cell 5Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 265Leukemia 183Carcinoma, Non-Small-Cell Lung 168Lymphoma 159Lung Neoplasms 148Prostatic Neoplasms 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Ovarian Neoplasms 117Colorectal Neoplasms 115Sarcoma 108Central Nervous System Neoplasms 107Head and Neck Neoplasms 98Leukemia, Myeloid, Acute 95Multiple Myeloma 93Squamous Cell Carcinoma of Head and Neck 83Rectal Neoplasms 77Colonic Neoplasms 71Uterine Cervical Neoplasms 65Neoplasm Metastasis 65Neuroblastoma 64Carcinoma, Ovarian Epithelial 64Brain Neoplasms 64Neoplasms 63Fallopian Tube Neoplasms 62Lymphoma, Large B-Cell, Diffuse 61Astrocytoma 59Melanoma 58Leukemia, Lymphocytic, Chronic, B-Cell 56Burkitt Lymphoma 56Hodgkin Disease 55

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Myelography 1Lenalidomide 1Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Smoldering Multiple Myeloma × Clear all
NCT03937635 2026-05-15

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Eastern Cooperative Oncology Group

Phase 3 Recruiting
288 enrolled
Plasma cell

Smoldering Multiple Myeloma

NCT06237803 2025-12-03

EMN36

European Myeloma Network B.V.

Recruiting
6,000 enrolled
Other hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Leukemia, Plasma Cell, Multiple Myeloma

NCT06183489 2024-10-18

ERASMM

European Myeloma Network B.V.

Phase 2 Recruiting
50 enrolled
Plasma cell

Smoldering Multiple Myeloma

NCT04144387 2024-03-06

CARRISMM

Intergroupe Francophone du Myelome

Phase NA Active not recruiting
395 enrolled
Plasma cell

Smoldering Multiple Myeloma

NCT00919139 2015-04-03

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

SWOG Cancer Research Network

Completed
190 enrolled
LymphoidPlasma cell

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡